Jiandong Xu's most recent trade in Estrella Biopharma Inc was a trade of 509,204 Nonstatutory Share Option done . Disclosure was reported to the exchange on Oct. 30, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Estrella Biopharma Inc | Jiandong Xu | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2024 | 509,204 | 509,203 | - | - | Nonstatutory Share Option | |
| Estrella Biopharma Inc | Jiandong Xu | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2024 | 490,796 | 490,796 | - | - | Incentive Share Option | |
| Denali Capital Acquisition | Jiandong Xu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Aug 2024 | 500,000 | 1,432,500 | - | - | Class B Ordinary Shares |